NO873835L - Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.

Info

Publication number
NO873835L
NO873835L NO873835A NO873835A NO873835L NO 873835 L NO873835 L NO 873835L NO 873835 A NO873835 A NO 873835A NO 873835 A NO873835 A NO 873835A NO 873835 L NO873835 L NO 873835L
Authority
NO
Norway
Prior art keywords
pyridines
procedure
preparation
therapeutic active
carbocyclic
Prior art date
Application number
NO873835A
Other languages
English (en)
Other versions
NO873835D0 (no
Inventor
Bradley William Caprathe
Juan Carlos Jaen
Lawrence David Wise
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO873835D0 publication Critical patent/NO873835D0/no
Publication of NO873835L publication Critical patent/NO873835L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO873835A 1986-09-15 1987-09-14 Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner. NO873835L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90744586A 1986-09-15 1986-09-15
US07/075,002 US4762843A (en) 1986-09-15 1987-07-17 Hetero [f] fused carbocyclic pyridines as dopaminergic agents

Publications (2)

Publication Number Publication Date
NO873835D0 NO873835D0 (no) 1987-09-14
NO873835L true NO873835L (no) 1988-03-16

Family

ID=26756318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873835A NO873835L (no) 1986-09-15 1987-09-14 Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.

Country Status (10)

Country Link
US (1) US4762843A (no)
EP (1) EP0260642A3 (no)
KR (1) KR880003960A (no)
AU (1) AU596212B2 (no)
DK (1) DK478887A (no)
FI (1) FI873956A (no)
NO (1) NO873835L (no)
NZ (1) NZ221675A (no)
PH (1) PH24195A (no)
PT (1) PT85696B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341370C (en) * 1988-04-28 2002-06-18 John J. Powinski Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
GB8828669D0 (en) * 1988-12-08 1989-01-11 Lilly Industries Ltd Organic compounds
US4957921A (en) * 1989-12-06 1990-09-18 Warner-Lambert Company Substituted cyclohexanols as central nervous system agents
US5650521A (en) * 1995-12-29 1997-07-22 Guilford Pharmaceuticals Inc. Pyrrolidine derivatives
US5925666A (en) * 1995-12-29 1999-07-20 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives
AR008395A1 (es) * 1996-07-09 2000-01-19 Astra Pharma Prod Compuesto derivado de pirimidina, composicion farmaceutica que lo comprende, procedimiento para prepararlo, y compuesto intermediario util parallevar a cabo dicho procedimiento.
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
CN1897950A (zh) 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859291A (en) * 1973-10-01 1975-01-07 Morton Norwich Products Inc 9-(p-anisidino)-7-methyl-(1h)-pyrazolo(3,4-f)quinoline
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
CA1246578A (en) * 1982-03-29 1988-12-13 John H. Musser 2-oxo-1,3-oxazolo[4,5]quinolines useful as anti-allergy agents
ES524452A0 (es) * 1982-11-03 1985-04-16 Lilly Co Eli Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.
US4596871A (en) * 1983-09-26 1986-06-24 Eli Lilly And Company Pyrazole-ring alkylated pyrazoloquinolines
US4501890A (en) * 1983-09-26 1985-02-26 Eli Lilly And Company Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines
IL72730A (en) * 1983-09-26 1987-10-30 Lilly Co Eli Octahydro-2-pyrimido(4,5-g)quinolinamines,their preparation and pharmaceutical compositions containing them
US4507478A (en) * 1983-09-26 1985-03-26 Eli Lilly And Company 2-Mercaptopyrimidohexahydroquinolines and related compounds
US4537893A (en) * 1984-04-27 1985-08-27 Eli Lilly And Company Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors
GR851895B (no) * 1984-08-02 1985-12-03 Lilly Co Eli
NZ212947A (en) * 1984-08-03 1988-07-28 Lilly Co Eli Preparation of tricyclic quinoline derivatives
US4552956A (en) * 1984-08-15 1985-11-12 Eli Lilly And Company Partially hydrogenated pyrazolo, pyrimido and thiazolo[1,4]benzoxazines
NZ224745A (en) * 1987-05-29 1990-09-26 Merrell Dow Pharma Tricyclic oxazolone derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
AU596212B2 (en) 1990-04-26
FI873956A0 (fi) 1987-09-11
NZ221675A (en) 1990-08-28
PT85696A (en) 1987-10-01
US4762843A (en) 1988-08-09
DK478887A (da) 1988-03-16
EP0260642A3 (en) 1989-08-09
FI873956A (fi) 1988-03-16
EP0260642A2 (en) 1988-03-23
PH24195A (en) 1990-04-10
PT85696B (pt) 1991-03-20
KR880003960A (ko) 1988-05-31
AU7815687A (en) 1988-03-17
DK478887D0 (da) 1987-09-14
NO873835D0 (no) 1987-09-14

Similar Documents

Publication Publication Date Title
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO864130L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO871044D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO873835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO894423D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanolaminer.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.